Enzo Biochem Financial Statements
Enzo Biochem Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | July |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Enzo Biochem Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 52.9 | 39.8 | 43.4 |
| Gross Profit ($ mil.) | 29.7 | 23.7 | 28.7 |
| Operating Income ($ mil.) | (21.0) | (20.1) | 3.7 |
| Total Net Income ($ mil.) | (13.3) | (15.7) | 3.0 |
| Diluted EPS (Net Income) | (0.38) | (0.49) | 0.09 |
Enzo Biochem Quarterly Statements
| Quarter Ending Apr 08 | Quarter Ending Jan 08 | Quarter Ending Oct 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 19.0 | 18.2 | 19.5 |
| Gross Profit ($ mil.) | 9.3 | 9.0 | 9.9 |
| Operating Income ($ mil.) | (2.7) | (5.2) | (2.8) |
| Total Net Income ($ mil.) | (2.1) | (4.1) | (1.2) |
| Diluted EPS (Net Income) | (0.06) | (0.11) | (0.03) |
Enzo Biochem Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 7.20 | 0.88 | 1.55 |
| Price/Earnings Ratio | -- | 18.12 | 15.75 |
| Price/Book Ratio | 3.92 | 2.13 | 1.49 |
| Price/Cash Flow Ratio | -- | 8.44 | 9.68 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Enzo Biochem Financial Ratios
Enzo Biochem Competitive Intelligence
| Bio-Reference Labs | LabCorp | Quest Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 250.4 | 4,068.2 | 6,704.9 |
| Employees | 1,648 | 26,000 | 43,500 |
| Market Cap ($ mil.) | 371.6 | 8,037.0 | 10,624.1 |
Competitive Landscape
